Founded by CEO Dag Kittlaus, the former co-founder of the virtual assistants Siri and Viv, Riva Health develops a potentially breakthrough cardiovascular technology product for measuring and managing hypertension.
Tuhin Sinha, Ph.D., a cofounder of the Health eHeart Study conducted by the University of California, San Francisco, is the company’s president.
Riva Health uses the camera flash on smartphones to take a reading for monitoring and tracking blood pressure changes. The company is making efforts for clinical approval as an early detection point for patients with the risk of heart disease. In addition, the company plans to monetize its platform by being a dependable solution for physicians on a daily basis.
Riva’s software is pending FDA approval and is expected to be launched to the public at the end of 2021 or beginning of 2022.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.